Genomma Lab (Mexico) Insiders

LABB Stock  MXN 25.78  0.27  1.06%   
Genomma Lab employs about 2.3 K people. The company is managed by 25 executives with a total tenure of roughly 89 years, averaging almost 3.0 years of service per executive, having 91.88 employees per reported executive. Break down of Genomma Lab's management performance can provide insight into the company performance.
Jorge Valderrama  CEO
Chief Executive Officer
Rodrigo Aspra  Chairman
Chairman of the Board, Independent Director
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Genomma Lab Internacional. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Genomma Lab Management Team Effectiveness

The company has return on total asset (ROA) of 0.0921 % which means that it generated a profit of $0.0921 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1264 %, meaning that it generated $0.1264 on every $100 dollars invested by stockholders. Genomma Lab's management efficiency ratios could be used to measure how well Genomma Lab manages its routine affairs as well as how well it operates its assets and liabilities.

Genomma Lab Workforce Comparison

Genomma Lab Internacional is currently regarded as number one stock in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 139,704. Genomma Lab claims roughly 2,297 in number of employees contributing just under 2% to equities under Health Care industry.
The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.2 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.2.

Genomma Lab Internacional Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Genomma Lab Internacional Price Series Summation is a cross summation of Genomma Lab price series and its benchmark/peer.

Genomma Lab Notable Stakeholders

A Genomma Lab stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Genomma Lab often face trade-offs trying to please all of them. Genomma Lab's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Genomma Lab's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Jorge ValderramaChief Executive OfficerProfile
Rodrigo AspraChairman of the Board, Independent DirectorProfile
Alejandro PatinoExecutive Vice President of Human Capital and Commercial ExpansionProfile
Antonio GallandExecutive Vice President, Chief Financial and Chief Administrative OfficerProfile
Santiago PelaezVice President of Industrial and Research and DevelopmentProfile
Juan SparvieriChief Operating Officer, Vice PresidentProfile
Scott EmersonIndependent DirectorProfile
Jorge MunozIndependent DirectorProfile
Ignacio RodriguezIndependent DirectorProfile
Juan GavitoIndependent DirectorProfile
Hector GonzalezIndependent DirectorProfile
Javier CastillaIndependent DirectorProfile
Sabrina AspraDirector of International Operations, DirectorProfile
Juan AlonsoIndependent DirectorProfile
Cesar LopezVice President of Global MarketingProfile
Efran CrdovaDeputy SecProfile
Carlos AlonsoIndependent DirectorProfile
Marianne VelascoGlobal HRProfile
L PorresLegal OfficerProfile
Burkhard WittekDirectorProfile
Alejandro PatioMedia, RelationsProfile
Engineer GallandExec CFOProfile
Mximo JudaAdvisorProfile
Daniel NeriaHead RelationsProfile
Leticia HerreraGlobal Director of Human Resources (Genomma Experience)Profile

About Genomma Lab Management Performance

The success or failure of an entity such as Genomma Lab Internacional often depends on how effective the management is. Genomma Lab management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Genomma management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Genomma management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Genomma Lab Internacional, S.A.B. de C.V. together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico, the United States, and Latin America. Genomma Lab Internacional, S.A.B. de C.V. was founded in 1996 and is based in Mexico City, Mexico. GENOMMA LAB operates under Drug ManufacturersSpecialty Generic classification in Mexico and is traded on Mexico Stock Exchange. It employs 1451 people.
Please note, the imprecision that can be found in Genomma Lab's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Genomma Lab Internacional. Check Genomma Lab's Beneish M Score to see the likelihood of Genomma Lab's management manipulating its earnings.

Genomma Lab Workforce Analysis

Traditionally, organizations such as Genomma Lab use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Genomma Lab within its industry.

Genomma Lab Manpower Efficiency

Return on Genomma Lab Manpower

Revenue Per Employee6.7M
Revenue Per Executive619.5M
Net Income Per Employee569.4K
Net Income Per Executive52.3M

Additional Tools for Genomma Stock Analysis

When running Genomma Lab's price analysis, check to measure Genomma Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genomma Lab is operating at the current time. Most of Genomma Lab's value examination focuses on studying past and present price action to predict the probability of Genomma Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genomma Lab's price. Additionally, you may evaluate how the addition of Genomma Lab to your portfolios can decrease your overall portfolio volatility.